Mark L. Portnoy - 22 Dec 2021 Form 4 Insider Report for CRYO CELL INTERNATIONAL INC (CCEL)

Role
Co-CEO, Director
Signature
/s/ Mark Portnoy
Issuer symbol
CCEL
Transactions as of
22 Dec 2021
Net transactions value
+$1,472,400
Form type
4
Filing time
27 Dec 2021, 16:00:16 UTC
Previous filing
26 Aug 2021
Next filing
14 Apr 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding CCEL Common Stock 42,266 22 Dec 2021 By 401K
holding CCEL Common Stock 71,529 22 Dec 2021 By Partnership F1
holding CCEL Common Stock 762,514 22 Dec 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CCEL Stock Option Award $245,400 +20,000 $12.27 20,000 22 Dec 2021 Common Stock 20,000 $12.27 Direct F3
transaction CCEL Stock Option Award $1,227,000 +100,000 $12.27 100,000 22 Dec 2021 Common Stock 100,000 $12.27 Direct F4
holding CCEL Stock Option 59,459 22 Dec 2021 Common Stock 59,459 $3.14 Direct
holding CCEL Stock Option 20,000 22 Dec 2021 Common Stock 20,000 $7.92 Direct
holding CCEL Stock Option 22,222 22 Dec 2021 Common Stock 22,222 $7.53 Direct
holding CCEL Stock Option 20,000 22 Dec 2021 Common Stock 20,000 $7.28 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares of Common Stock held by Capital Asset Fund #1 Limited Partnership, as to which Mark L. Portnoy may be deemed the beneficial owner as its general partner.
F2 Stock options will vest 1/3 on the date of grant, 1/3 on December 1, 2020 and 1/3 on December 1, 2021.
F3 Stock options fully vest upon issuance.
F4 Stock options vest immediately if the price of the Company's stock reaches $25.00 per share during the seven-year option term.